PREVIOUS
✖
10,000 TB genome samples
April 2 , 2025
2 days
79
0
- The Department of Biotechnology (DBT) has completed the genomic sequencing of a third, or 10,000 samples, of the target of 32,500 samples of mycobacterium tuberculosis.
- It aims to improve the understanding of drug-resistant TB and capture unique genomic features of the TB bacterium in India.
- Of the sequenced samples, 7% are said to be resistant to a single drug.
- The genome sequencing initiative, called part of “Dare2eraD TB”, is an umbrella programme 2022.
- India has 1,990 cases per million in 2022, down from 2,370 per million in 2015.
- India accounts for about 28% of new TB cases worldwide.
Leave a Reply
Your Comment is awaiting moderation.